Cost-Effectiveness of IL28Β Genotype-Guided Protease Inhibitor Triple Therapy versus Standard of Care Treatment in Patients with Hepatitis C Genotypes 2 or 3 Infection

Publisher: Karger

E-ISSN: 1662-8063|17|5-6|306-319

ISSN: 1662-4246

Source: Public Health Genomics, Vol.17, Iss.5-6, 2014-09, pp. : 306-319

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract